- Home
- GERN vs SWIM Comparison
GERN vs SWIM Comparison
Compare GERN & SWIM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GERN
- SWIM
- Stock Information
- Founded
- GERN 1990
- SWIM 1956
- Country
- GERN United States
- SWIM United States
- Employees
- GERN N/A
- SWIM N/A
- Industry
- GERN Biotechnology: Pharmaceutical Preparations
- SWIM Plastic Products
- Sector
- GERN Health Care
- SWIM Industrials
- Exchange
- GERN Nasdaq
- SWIM Nasdaq
- Market Cap
- GERN 823.0M
- SWIM 916.0M
- IPO Year
- GERN 1996
- SWIM 2021
- Fundamental
- Price
- GERN $1.27
- SWIM $7.75
- Analyst Decision
- GERN Buy
- SWIM Hold
- Analyst Count
- GERN 8
- SWIM 3
- Target Price
- GERN $3.71
- SWIM $6.93
- AVG Volume (30 Days)
- GERN 5.5M
- SWIM 590.2K
- Earning Date
- GERN 11-06-2025
- SWIM 11-04-2025
- Dividend Yield
- GERN N/A
- SWIM N/A
- EPS Growth
- GERN N/A
- SWIM N/A
- EPS
- GERN N/A
- SWIM N/A
- Revenue
- GERN $164,447,000.00
- SWIM $521,828,000.00
- Revenue This Year
- GERN $175.15
- SWIM $9.17
- Revenue Next Year
- GERN $56.61
- SWIM $5.38
- P/E Ratio
- GERN N/A
- SWIM N/A
- Revenue Growth
- GERN 11877.20
- SWIM N/A
- 52 Week Low
- GERN $1.09
- SWIM $4.56
- 52 Week High
- GERN $4.83
- SWIM $8.46
- Technical
- Relative Strength Index (RSI)
- GERN 41.64
- SWIM 50.03
- Support Level
- GERN $1.23
- SWIM $7.67
- Resistance Level
- GERN $1.33
- SWIM $8.06
- Average True Range (ATR)
- GERN 0.07
- SWIM 0.28
- MACD
- GERN -0.02
- SWIM -0.08
- Stochastic Oscillator
- GERN 13.79
- SWIM 12.40
About GERN Geron Corporation
Geron Corp is a clinical-stage biopharmaceutical company focused on the research and development of cancer treatments. The company's drug in development, Imelstat, is being tested for the treatment of myelodysplastic syndromes, which are disorders of the blood, and myelofibrosis, which is a rare blood cancer affecting bone marrow. The company earns revenue through collaboration agreements, milestones, royalties, and licensing arrangements. Geron possesses various rights to this drug. The company operates as a single segment being, the development of therapeutic products for oncology.
About SWIM Latham Group Inc.
Latham Group Inc is a designer, manufacturer, and marketer of in-ground residential swimming pools, liners, and covers in North America, Australia, and New Zealand. It derives a majority of its revenue from the United States.